Endocrinology
From the Journals
Only a third of adults with diabetes receive ADA-recommended care
In 2017-2018, only one in three received all of five care elements recommended by the American Diabetes Association.
From the Journals
Most kids with type 1 diabetes and COVID-19 in U.S. fared well
News
Acella recalls NP Thyroid lots found to have reduced potency
The voluntary recall of the desiccated thyroid product is the third in a year due to potency issues.
From the Journals
Being overweight ups risk of severe COVID-19 in hospital
This research “adds to the known data on the associations between obesity and severe COVID-19 disease and extends these findings” to patients who...
From the Journals
Cardiovascular disease remains leading cause of type 2 diabetes mortality
Lab values topped clinical variables in predicting all-cause death among a high-risk population.
News
FDA okays new indication for alirocumab in homozygous FH
The FDA approved use of the PCSK9 inhibitor as an add-on therapy in adults with rare homozygous familial hypercholesterolemia.
From the Journals
Use of complimentary and alternative medicine common in diabetes patients
Roughly half of diabetes patients may be using complementary and alternative medicine, but most don’t tell their healthcare providers.
Conference Coverage
COVID-19 can cause atypical thyroid inflammation
Patients with thyroid abnormalities during acute COVID-19, or who develop such symptoms, should have thyroid function checked every 6 months for a...
Conference Coverage
1 in 3 on levothyroxine take meds that interfere with thyroid tests
Around a third of older patients taking levothyroxine are prescribed other drugs that can interfere with thyroid function tests, shows the first...
Conference Coverage
Imaging alternative to AVS could boost detection of primary aldosteronism
From the Journals
Dose-related AFib risk with omega-3 fatty acids?
The VITAL-RHYTHM study, showing no significant effect of low-dose omega-3 fatty acids or vitamin D on AFib risk, has been published. A look at...